Blair William & CO Pds Biotechnology Corp Call Options Transaction History
Blair William & CO
- $34.8 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
55Shares Held
8.26MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$5.35 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.83 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$589,2300.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$529,8360.0% of portfolio
-
Ubs Group Ag251KShares$303,8980.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $34.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...